Previous Article | Next Article ![]()
J Virol, June 1998, p. 5085-5092, Vol. 72, No. 6
Infectious Disease Laboratory, The Salk
Institute for Biological Studies, La Jolla, California 92037
Received 20 January 1998/Accepted 9 March 1998
The hepatitis B virus posttranscriptional regulatory element
(HBVPRE) is a cis-acting RNA element that partially
overlaps with enhancer I and is required for the cytoplasmic
accumulation of HBV surface RNAs. We find that the closely related
woodchuck hepatitis virus (WHV), which has been shown to lack a
functional enhancer I, also contains a posttranscriptional
regulatory element (WPRE). Deletion analysis suggests that the WPRE
consists of three independent subelements. Comparison of the bipartite
HBVPRE and tripartite WPRE activities reveals that the tripartite WPRE
is two to three times more active than the bipartite HBVPRE. Mutation of a single WPRE subelement decreases WPRE activity to the level of the
HBVPRE. Bipartite and tripartite chimeras of the WPRE and HBVPRE
possess activities which suggest that elements containing three
subelements are posttranscriptionally stronger than those containing
two. These data demonstrate that the posttranscriptional regulatory
element is conserved within the mammalian hepadnaviruses and that its
strength is determined by the number of subelements within the RNA.
The Hepadnaviridae family
consists of closely related yet species-specific DNA viruses which
replicate via reverse transcription (8, 19). Studies of
human hepatitis B virus (HBV) and woodchuck hepatitis virus (WHV) have
shown that both viruses are mainly hepatotropic and contain four open
reading frames that encode the major viral proteins: core, polymerase,
surface, and X. The two viruses show approximately 59% nucleotide
identity and have similar physical maps (7). Although
spliced HBV RNAs have been reported, the major HBV and WHV proteins are
translated from unspliced RNAs (28). The viral RNAs
terminate at the same polyadenylation site and have a common 3'
terminus (Fig. 1A).
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Woodchuck Hepatitis Virus Contains a Tripartite
Posttranscriptional Regulatory Element
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (38K):
[in a new window]
FIG. 1.
Schematic representation of the HBV and WHV genomes.
(A) The negative and discontinuous positive strands of HBV relaxed
DNA are shown in the center circle (bold). The HBV liver-specific
enhancer (Enh) I and the WHV and HBV liver-specific enhancer II are
shown as rectangles. The four classes of hepadnavirus RNAs are
represented by the curved arrows. The RNAs encode core (C), presurface
(preS), surface (S), and X proteins. The shaded region within these
RNAs indicates the position of the HPRE. (B) Comparison of the PRE and
enhancer I regions of HBV and WHV. The darkened regions correspond
to the open reading frames of the polymerase (Pol) and X proteins. The
regions containing the HPRE
and HBVPRE
subelements are
indicated. Homologous nucleotides (nt) are aligned, and the fragments
are drawn to scale. The HBV enhancer (enh) is indicated.
The correlation of HBV infection with an increased risk of hepatocellular carcinoma has stimulated investigation of the virus-host interactions and gene regulation of Hepadnaviridae. Transcription of the major viral proteins is mediated by four promoters which are partially regulated by HBV enhancers I and II. HBV enhancers I and II have been shown to upregulate heterologous promoters and are believed to be key determinants of HBV hepatotropism (10, 27). Both enhancers are liver specific, although enhancer I retains lower activity levels in some nonhepatic cells (25, 33, 35). HBV enhancer I maps upstream of the X open reading frame and consists of a modulatory domain, a core enhancer domain, and a basal X promoter domain (3, 30); enhancer II maps to the core promoter region and is thought to influence levels of genomic RNA (34).
The transcriptional regulatory elements of WHV are not as thoroughly characterized. Mapping studies have confirmed that WHV contains promoters analogous to the major HBV promoters (2, 29). Recent studies have shown that WHV enhancer II is a strongly liver-specific enhancer that regulates the production of pregenomic RNAs, which is an important rate-limiting step of hepadnavirus replication (6, 32). Surprisingly, the WHV region homologous to HBV enhancer I lacks enhancer activity in the three human liver cell lines tested (2, 6, 31). This region failed to activate transcription of the four viral promoters as well as a heterologous thymidine kinase (tk) promoter. The authors suggest that either the human liver cells do not express the required transcription factors or major differences exist in the transcriptional control of HBV and WHV (2).
The HBV posttranscriptional regulatory element (HBVPRE) is
an orientation-dependent cis-acting RNA element that
partially overlaps with enhancer I and is required for the cytoplasmic
localization of HBV surface RNAs (Fig. 1B) (13, 15). The
HBVPRE function is independent of virally encoded proteins, and
it is believed that cellular proteins interact with the
HBVPRE and mediate the HBVPRE posttranscriptional effect. The
HBVPRE can functionally substitute for the human immunodeficiency
virus type 1 (HIV-1) Rev-Rev-responsive element (RRE) complex in a
transient transfection reporter assay (13, 16). In addition,
the HBVPRE can increase the amount of intronless cytoplasmic RNAs
of a normally intron-dependent
-globin cDNA, consistent with the
notion that the HBVPRE functionally replaces an intron during RNA
processing (16). Deletion analysis suggests that the
HBVPRE consists of two independent subelements within
nucleotides 1151 to 1684 (4). These subelements, termed HBVPRE
(HPRE
) and HBVPRE
(HPRE
), are
encompassed by nucleotides 1151 to 1412 and 1413 to 1684, respectively. A single HBVPRE subelement displays a low level of
posttranscriptional activity, and both subelements function
cooperatively when duplicated. In addition, the order of HPRE
and
HPRE
can be switched, suggesting that the subelements are modular
(4). The subelements most likely represent distinct binding
sites for cellular RNA binding proteins.
A number of reports have suggested that the posttranscriptional mechanism of the HBVPRE may be RNA export (4, 13, 16). The first-identified and best-characterized viral export system is the HIV-1 Rev-RRE complex. HIV-1 Rev has been shown to directly mediate RNA export via its nuclear export signal (5). The Mason-Pfizer monkey virus (MPMV) encodes a cis-acting RNA export element, termed the constitutive transport element (CTE), which is required for the export of the intron-containing genomic RNA (1). An additional element has been found in the intronless tk gene of herpes simplex virus type 1 (18). Liu and Mertz reported that hnRNP L binds to a site within the tk gene and, using mutants of the tk gene, showed a correlation between hnRNP L binding and cytoplasmic RNA accumulation. All of these cis-acting elements are essential for the cytoplasmic localization of viral RNA and, with the exception of the complex retrovirus elements, are thought to interact with cellular RNA binding proteins.
A posttranscriptional regulatory element (PRE) has not yet been
identified in WHV. The similarities between WHV and HBV suggest that a PRE is present, yet the lack of a WHV enhancer I raises the
possibility that functional differences exist in this region. To
address whether the role of the PRE is conserved between HBV and
WHV, we sought to map the putative WHV PRE (WPRE) and determine whether
the gross structure is conserved between WPRE and HBVPRE. We find
that the WPRE consists of three subelements, termed WPRE
, WPRE
, and WPRE
. The PRE
and PRE
subelements are
homologous between the two viruses, while the WPRE
region
corresponds to the region containing the HBV enhancer I. The
tripartite WPRE displays significantly stronger activity than the
bipartite HBVPRE, demonstrating that the strength of the
posttranscriptional effect is determined by the number of subelements
in the RNA.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Construction of reporter plasmids.
The cytomegalovirus (CMV)
surface expression construct was synthesized by amplifying nucleotides
135 to 1685 from GenBank accession no. D00329. The amplified fragment
was digested with SacI and BglII and
ligated into a SacI-BglII-digested CMV expression construct. The HBVPRE was then removed from this construct by digestion with EcoRV. The vector was religated to yield the
HBVPRE surface expression vector. The HPRE(963-1684) and
WPRE(1093-1684) fragments were then ligated into the ClaI
site. The pDM138 vector system has been previously described
(11). To construct the pDM138 reporter derivatives, 32-base
oligonucleotides were synthesized and used to PCR amplify the fragment
of interest from the DNA template. The oligonucleotides consisted of
the 5' sequence GCGGGATCCATCGAT followed by 20 bases of the
HBVPRE or WPRE sequence. The WPRE fragments were amplified from the
viral DNA template of WHV accession no. J04514. The amplified fragments
were purified on a 2% agarose gel, digested with ClaI, and
subsequently ligated into the ClaI site of pDM138. The pGL3
vector (Promega) was digested with SmaI, and the
ClaI-digested WPRE and HBVPRE fragments were Klenow
enzyme-treated and ligated into the pGL3 vector. The mCC1 mutant was
also synthesized via PCR. The HPRE
/WPRE
and WPRE
/HPRE
constructs were constructed by PCR mutagenesis. Briefly, a mutant WPRE
was synthesized with a single nucleotide change at nucleotide 1533, which produces a BamHI site (WPRE BamHI), and
cloned into the ClaI site of pDM138. The mutant and the WPRE
activities were identical (data not shown). p138HBVPRE(963-1684)
and p138WPRE BamHI were digested with ClaI and
BamHI. The 5' and 3' fragments from both digestions were gel isolated. The fragments were then ligated with the corresponding fragment into the pDM138 vector.
Tissue culture and transfections. CV1 cells were grown in 10-cm-diameter plates containing Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Before the cells were transfected, the medium was removed and the DNA-CaPO4 mix was added directly to the naked cells. After 10 min, 5 ml of medium was placed back onto the cells. The medium was changed 16 h after transfection. The cells were harvested 36 to 48 h later. For the chloramphenicol acetyltransferase (CAT) assays, CV1 cells were transfected in triplicate with 2 µg of reporter plasmid, 1 µg of pCH110, and 7 µg of pUC118 by the CaPO4 method. For the luciferase assays, CV1 cells were transfected when the 10-cm-diameter dish was approximately 30% confluent. The cells were transfected in triplicate with 2 µg of the luciferase reporter, 1 µg of pCH110, and 7 µg of pUC118. Luciferase activity was determined by standard methods. To assay for surface expression, CV1 cells were transfected in duplicate with 25 µg of surface expression vector and 5 µg of CMV secreted alkaline phosphatase. The medium was changed approximately 16 h after transfection. The spent medium was harvested 48 h later.
RNA isolation and analysis. HEK 293 cells were transfected with 10 µg of p138 vector, 1 µg of pCH110, and 2 µg of pGL3. Cells were resuspended in cytoplasmic lysis buffer (10 mM HEPES [pH 7.8], 10 mM KCl, 0.1 mM EDTA, 20% glycerol, 0.5% Nonidet P-40). The lysed cells were spun at 8,000 × g; the supernatant was recovered and spun for an additional 5 min at 14,000 × g. The supernatant was then transferred to 1 ml of RNA Stat-50LS (Tel-Test). The nuclear pellet from the first spin was resuspended in 1 ml of cytoplasmic lysis buffer and then spun at 8,000 × g for 3 min. The supernatant was discarded, and the pellet was resuspended in 800 µl of nuclear buffer (10 mM Tris [pH 8.4], 1.5 mM MgCl2, 140 mM NaCl, 20% glycerol). The sample was centrifuged at 8,000 × g, and the supernatant was discarded. The pellet was then resuspended in 300 µl of nuclear buffer and lysed with 1 ml of RNA Stat-50LS. The manufacturer's RNA Stat-50 protocol was followed. After RNA purification, the samples were DNase treated for 15 min at 37°C. Five micrograms of nuclear RNA and 10 µg of cytoplasmic RNA were loaded onto a 1% agarose/formaldehyde gel.
Surface expression radioimmunoassay. The spent medium from duplicate transfections was assayed for the presence of surface antigen with an Ausria II kit (Abbott Laboratories) and quantitated in a gamma counter. As an indicator of transfection efficiencies, the medium was also assayed for the presence of secreted alkaline phosphatase.
CAT assays.
CV1 cells were lifted by using
phosphate-buffered saline and 5 mM EDTA and resuspended in 150 µl of
reporter lysis buffer (Promega). The lysates were spun briefly to
pellet insoluble cell debris. An aliquot of each lysate was assayed for
-galactosidase activity, which was then used to normalize each
lysate for transfection efficiency. The normalized lysates, equalized
with reporter lysis buffer, were incubated at 37°C for 30 min to
several hours with 1.5 nCi of [14C]chloramphenicol (50 to
60 mCi/mmol) per µl and 1 mM acetyl coenzyme A in 50-µl volumes.
Substrate and products were resolved by thin-layer chromatography and
quantitated by a PhosphorImager (Molecular Dynamics).
| |
RESULTS |
|---|
|
|
|---|
In this study, the nucleotide numbering schemes of accession no. J04514 (WHV) and D00329 (HBV) were used. Consequently, homologous nucleotides are offset by 130 bases. For example, WHV nucleotide 1093 is homologous to HBV nucleotide 963 (Fig. 1B). The schematic in each figure is drawn to scale, and the homologous nucleotides of WPRE and HBVPRE are aligned. The posttranscriptional activity of an element will be discussed as a percentage of the WPRE activity.
WHV contains a PRE.
To determine whether WHV contains a PRE
similar to the HBVPRE, the HBV surface expression constructs
depicted in Fig. 2A were transiently
transfected into CV1 cells. CV1 cells were used to avoid any
liver-specific transcriptional effects of enhancer I. The results
(Fig. 2A) confirm that
HBVPRE exhibits background levels of
surface protein expression. Surface protein expression was increased
6.1-fold by the HBVPRE, while the WPRE induced a 8.6-fold increase.
Hence, the region in WHV homologous to the HBVPRE can rescue
HBV surface expression.
|
The WPRE contains three subelements. To identify the critical functional regions of the WPRE, a series of 5' and 3' deletions of nucleotides 900 to 1800, shown in Fig. 3A, were assayed for posttranscriptional activity in the pDM138 reporter assay. Figure 3B illustrates that p138WPRE(900-1800) can induce the expression of CAT in the pDM138 assay. This activity is orientation dependent (data not shown). 138WPRE(1093-1684) possesses 85% of the activity of p138WPRE(900-1800), while p138WPRE(1300-1684) is only 22% as active as p138WPRE (900-1800). p138WPRE(1508-1684) exhibits 12% of p138WPRE(900-1800) activity. To continue the analysis of the WPRE, we assayed a series of 3' deletions of nucleotides 1093 to 1684 for posttranscriptional activity. Figure 3C illustrates that p138WPRE(1093-1508) is 30% and p138WPRE(1093-1250) is approximately 9% as active as p138WPRE(1093-1684).
|
subelement. The 30% activity of
p138WPRE(1093-1508) suggests that WPRE nucleotides 1093 to 1508 may
contain more than one subelement. One of these, given the sequence
homology of the region, is most likely the WHV homolog of HPRE
. A
third subelement, which we term WPRE
, is encompassed by nucleotides
1093 to 1250. These results demonstrate that the subelements of the
HBVPRE and WPRE are similarly organized but that the 5' end of the
WPRE, specifically nucleotides 1093 to 1250, and HBVPRE are
functionally different.
The three WPRE subelements function cooperatively.
To compare the activities of the WPRE and HBVPRE and
their respective subelements, CV1 cells were transiently transfected with the constructs depicted schematically in Fig.
4A. The results (Fig. 4B)
demonstrate that p138HBVPRE(963-1684) is significantly (39%) weaker than p138WPRE. The p138WPRE
, p138WPRE
, p138WPRE
, p138HBVPRE
, and p138HBVPRE
reporters display
approximately 12% of p138WPRE activity and twice the activity of the
pDM138 background control. The low but statistically significant
activities of the WPRE and HBVPRE subelements suggest that the
subelements are functionally equivalent and that the increased WPRE
activity is not due to the presence of an especially strong subelement.
|
and WPRE
, WPRE
, or
WPRE
were constructed (Fig. 4A). The data (Fig. 4C) indicate
that p138HBVPRE
was 12% as active as the WPRE whereas the
HBVPRE
/W
, HBVPRE
/W
, and
HBVPRE
/W
chimeras exhibited 46, 34, and 54% of
WPRE activity, respectively. Hence, each of the WPRE subelements
functions in a greater than additive fashion with the HBVPRE
subelement.
The posttranscriptional strength of the HBVPRE and WPRE
is determined by the number of subelements.
The functional
conservation of PRE
and PRE
within HBV and WHV suggests that
the subelement structures are also conserved. To identify the conserved
and variable regions of the PRE, 22 HBV, 5 WHV, and 2 ground
squirrel hepatitis virus (GSHV) isolate nucleotide sequences were
manually aligned. A phylogenetic comparative analysis highlighted two
covarying base pairs between HBV and WHV and one covarying base
pair between WHV and GSHV in the WPRE
region. Specifically, a C-G
base pair between WHV nucleotides 1428 and 1443 changes to a U-A base
pair in both HBV and GSHV. In addition, a U-A base pair between WHV
nucleotides 1432 and 1440 changes to an A-U base pair in HBV (Fig.
5A). An RNA secondary structure
prediction algorithm, Mulfold, was used to generate secondary structure
models of WHV nucleotides 1396 to 1475 (17). The secondary
structure model consists of an extended stem loop with a G-residue
bulge 3 bp from a 5-base loop. The predicted WPRE
secondary
structure has a free energy of
29.4 kcal/mol. The covarying
nucleotides are base paired in the predicted secondary structure model,
suggesting that the distal stem-loop is biologically relevant. The
covarying nucleotides are also based paired in the predicted secondary
structure models of HPRE
(data not shown). The covariational
analysis did not highlight any conserved base pairs in the WPRE
subelement (data not shown).
|
stem-loop structure was disrupted by mutating the C
residues at nucleotides 1429 and 1431 to G residues to create
p138WPREmCC1 (Fig. 5A). In addition, to test whether the predicted
stem-loop structure encompassed the entire WPRE
, nucleotides 1396 to
1475 were inserted into the pDM138 vector (p138WPRE
min). CV1
cells were transiently transfected with the reporters shown in
Fig. 5B, and the results are shown in Fig. 5C. Consistent with
previous experiments, p138HBVPRE(963-1684) was 41% as active
as p138WPRE(1093-1684). The activity of p138WPRE mCC1, 57% of the WPRE
activity, was closer to the activity of the bipartite HBVPRE.
p138WPRE
(1300-1507) and p138WPRE
min(1396-1475) were both 9% as
active as the WPRE. The data indicate that nucleotides 1396 to 1475, which encompass the predicted stem-loop structure, are sufficient for
WPRE
activity. Disruption of the predicted WPRE
structure
decreases WPRE activity by over 40%. The large decrease in activity
suggests that the three WPRE subelements function cooperatively to
increase WPRE activity.
These data imply that the posttranscriptional strength of the
hepadnavirus PREs is determined by the number of subelements present
within the RNA. To test whether the number of subelement determines the
posttranscriptional strength of an element, chimeric bipartite and
tripartite elements were constructed. These constructs, depicted
schematically in Fig. 6A, were
transiently transfected into CV1 cells, which were subsequently assayed
for CAT activity. In this experiment (Fig. 6B), the bipartite
p138HBVPRE(963-1684) was 41% as active as
138WPRE(1093-1684). The bipartite p138HBVPRE
/WPRE
chimera was 27% as active as WPRE, while the tripartite
p138WPRE
/HBVPRE
chimera was 76% as active as
p138WPRE. These data demonstrate that the subelements of the
HBVPRE and WPRE are interchangeable. In addition, the results
provide further evidence that the posttranscriptional strength of the
hepdnavirus PREs is determined by the number of subelements within the
RNA.
|
| |
DISCUSSION |
|---|
|
|
|---|
This is the first report of a PRE within WHV. The HBVPRE is required for the efficient expression of HBV surface protein, and its deletion abrogates surface expression (13, 15). Figure 2A demonstrates that the homologous region of WHV can also mediate expression of HBV surface protein. Although the WPRE encompasses a region that is homologous with HBV enhancer I, the results in Fig. 2B confirm previous reports that putative WHV enhancer I does not upregulate transcription activity. Hence, the WPRE effect on HBV surface expression is entirely posttranscriptional. The HBVPRE can mediate the cytoplasmic accumulation of unspliced RNA in the pDM138 assay, and the gross structure of the HBVPRE has been characterized by using this assay system. The WPRE can also mediate the cytoplasmic accumulation of unspliced pDM138 RNA (Fig. 2C). The WPRE increases the amount of unspliced RNA in both the nuclear and cytoplasmic compartments.
The PRE
and PRE
subelements are evolutionarily conserved between
WHV and HBV. The data presented in Fig. 3B suggest that WHV
nucleotides 1508 to 1684 encompass the minimal WPRE
subelement. The
HPRE
subelement was originally mapped to HBV nucleotides 1412 to
1684, which are homologous to WHV nucleotides 1542 to 1814. In Fig. 3C,
the drop in activity between p13WPRE(1093-1508) and
p13WPRE(1093-1250) is consistent with the WPRE
being
contained within nucleotides 1250 to 1507. This fragment is homologous
to HBV nucleotides 1120 to 1377, which encompass the HPRE
region. Figure 4B indicates that WPRE
(1300-1507),
WPRE
(1508-1684), HPRE
, and HPRE
are comparable and display
approximately 12% of WPRE activity.
The functional conservation of the HPRE
and WPRE
subelements
suggests that PRE
structure is also conserved. Phylogenetic comparative analysis highlighted two base pairs that covary within a
possible stem-loop structure in WPRE
. Two covarying base pairs within a helix is considered a nominal proof of a secondary structure model (21). RNA secondary structure predictions provided
further support for the covarying bases since the lowest-energy model predicted that the covarying bases were paired (Fig. 5A). Figure 5C
shows that mutating two residues within the stem decreased WPRE
activity by greater than 40%. In addition, the predicted stem-loop
structure of WPRE
, nucleotides 1396 to 1475, displayed the same
level of activity as p13WPRE(1300-1507). Other studies in our
laboratory demonstrate that the stem-loop structure is critical for
HBVPRE
activity (26). These data support the
hypothesis that WHV nucleotides 1396 to 1475 encompass the hepadnavirus
PRE
protein binding site.
Despite their similarities, the HBVPRE and WPRE exhibit
significantly different posttranscriptional activities. The difference between the HBVPRE and WPRE activities maps to the presence of a
third WPRE subelement within nucleotides 1093 to 1250. Figures 3C, 4B,
and 4C demonstrate that the third subelement, termed WPRE
, exhibits
12% of the WPRE activity and can function in a greater than additive
fashion with the HBVPRE
subelement. Previous studies have shown
that in HBV, this region does not display posttranscriptional regulatory activity (4, 15). The functional difference
between the HBVPRE and WPRE is surprising since this region is
evolutionarily well conserved between HBV and WHV. The high degree
of conservation is most likely due to the fact that these regions
contain two partially overlapping open reading frames, the X promoter,
the PRE, and HBV enhancer I. The WPRE
- and WPRE
-encoding
regions share 66.7% nucleotide identity with HBV. The HBV core
enhancer domain is almost completely conserved between the two viruses, but the 5' HBV enhancer modulatory domain is more divergent. This region, which has 60.7% nucleotide identity between HBV and WHV, encodes the WPRE
subelement in WHV. It is striking that WHV, which
lacks enhancer I activity, has a third PRE in the physical location of
the inactive enhancer I region.
Several observations suggest that the hepadnavirus PRE
subelements function cooperatively and that the cooperativity
of a third WPRE subelement results in greater WPRE activity. Each
of the PRE subelements, shown in Fig. 4B, displays approximately 12% of the WPRE activity. In Fig. 4C, each of the three mapped WPRE
subelements functions cooperatively with HBVPRE
. The
HBVPRE
/WPRE
, HBVPRE
/WPRE
, and
HBVPRE
/WPRE
chimeras exhibited 34, 46, and 54% of the
WPRE activity. The bipartite chimera activities are comparable to the
39% activity of the bipartite HBVPRE (Fig. 4B). In all of the
constructs assayed, the tripartite elements are significantly stronger
than bipartite elements. Figure 5C illustrates that mutation of a
single WPRE subelement, WPRE
, decreases the tripartite WPRE
activity by over 40%. In Fig. 6B, the tripartite WPRE
/HBVPRE
chimera was 76% as active as the tripartite
WPRE, but the bipartite HBVPRE and HBVPRE
/WPRE
chimeras were 41 and 27% as active, respectively. The increased WPRE
activity has also been observed in NIH 3T3 cells and chicken embryo
fibroblasts (data not shown). These data suggest that compared to two
subelements, the presence of three subelements greatly increases the
posttranscriptional strength of an element. It is interesting to
speculate that the presence of a third WPRE subelement compensates for
the lack of WHV enhancer I activity.
These data support a model in which the PRE-interacting proteins
function cooperatively and the posttranscriptional strength of an
element may be modulated by the number of proteins interacting with the
RNA element. The cellular proteins that interact with the WPRE and
HBVPRE have not yet been identified, but the characterized PRE
subelements most likely represent protein binding sites. A single
cellular protein may contact all of the PRE subelements or,
alternatively, distinct cellular proteins may bind to each. The
PRE binding protein(s) are most likely well conserved since the PREs
are functional in every cell line tested (data not shown). The
functional conservation of PRE
and PRE
subelements suggests that
the PRE
and PRE
binding proteins will interact with both the
HBVPRE and WPRE. Excluding the PRE
subelement, the secondary structures of the subelements have not been determined, and the predicted secondary structure models of WPRE
, WPRE
, and WPRE
do not show any striking similarities. In addition, the
WPRE
and WPRE
subelements do not contain any PRE
-like
secondary structures or sequence similarities (data not shown). Since
the subelements are modular and can function irrespective of order, we
postulate that multiple cellular proteins mediate hepadnavirus PRE
function.
The greater than additive effect of the PRE subelements is reminiscent of previous results obtained with the high-affinity binding sites of HIV-1 Rev and human T-cell leukemia virus type 1 Rex (9, 14). It has previously been suggested that the HBVPRE interacts with cellular proteins that directly export intronless RNAs, similar to the HIV-1 Rev-RRE system (4, 15, 23). However, we find that leptomycin B, a drug which specifically blocks Rev export, does not inhibit the activity of the HBVPRE or WPRE (20). Therefore, the HBVPRE and WPRE are not elements that directly interact with the Rev export pathway. However, the MPMV CTE can directly export intron lariats in Xenopus oocytes but is not inhibited by Rev-nuclear export signal peptides (22, 24). Hence, the HBVPRE may be more similar to the MPMV CTE in this respect. Alternatively, the HBVPRE may stimulate HBV RNA processing prior to the export of the RNA. The concise functional mapping of the WPRE will be useful for elucidating the mechanism of the hepadnavirus PREs and identifying their transactivating cellular proteins.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Didier Trono, Glen Otero, and Matthew Harris for critical comments and helpful discussions. We also thank Max Ader, Ginger Lucero, Peggy Funches, and George Smith for technical assistance and Leslie Barden and Allison Bocksruker for assistance in preparing the manuscript.
This work was supported by Arthur and Larry Kramer. J.E.D. was supported by NCI training grant T32 CA64041. T.J.H. is supported by the Gene and Ruth Posner Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Infectious Disease Laboratory, Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800. Phone: (619) 453-4100, ext. 1559. Fax: (619) 554-0341. E-mail: hope{at}salk.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bray, M.,
S. Prasad,
J. W. Dubay,
E. Hunter,
K. T. Jeang,
D. Rekosh, and M. L. Hammarskjold.
1994.
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
Proc. Natl. Acad. Sci. USA
91:1256-1260 |
| 2. | Di, Q., J. Summers, J. B. Burch, and W. S. Mason. 1997. Major differences between WHV and HBV in the regulation of transcription. Virology 229:25-35[Medline]. |
| 3. | Dikstein, R., O. Faktor, L. R. Ben, and Y. Shaul. 1990. Functional organization of the hepatitis B virus enhancer. Mol. Cell. Biol. 10:3682-3689. |
| 4. | Donello, J. E., A. A. Beeche, G. J. Smith, G. R. Lucero, and T. J. Hope. 1996. The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J. Virol. 70:4345-4351[Abstract]. |
| 5. | Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483[Medline]. |
| 6. | Fourel, G., F. Ringeisen, M. Flajolet, F. Tronche, M. Pontoglio, P. Tiollais, and M. A. Buendia. 1996. The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter. J. Virol. 70:8571-8583[Abstract]. |
| 7. |
Galibert, F.,
T. N. Chen, and E. Mandart.
1982.
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.
J. Virol.
41:51-65 |
| 8. | Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693[Medline]. |
| 9. | Grone, M., E. Hoffmann, S. Berchtold, B. R. Cullen, and R. Grassmann. 1994. A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology 204:144-152[Medline]. |
| 10. |
Honigwachs, J.,
O. Faktor,
R. Dikstein,
Y. Shaul, and O. Laub.
1989.
Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.
J. Virol.
63:919-924 |
| 11. |
Hope, T. J.,
X. J. Huang,
D. McDonald, and T. G. Parslow.
1990.
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
Proc. Natl. Acad. Sci. USA
87:7787-7791 |
| 12. |
Hope, T. J.,
D. McDonald,
X. J. Huang,
J. Low, and T. G. Parslow.
1990.
Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus.
J. Virol.
64:5360-5366 |
| 13. |
Huang, J., and T. J. Liang.
1993.
A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products.
Mol. Cell. Biol.
13:7476-7486 |
| 14. |
Huang, X. J.,
T. J. Hope,
B. L. Bond,
D. McDonald,
K. Grahl, and T. G. Parslow.
1991.
Minimal Rev-response element for type 1 human immunodeficiency virus.
J. Virol.
65:2131-2134 |
| 15. |
Huang, Z. M., and T. S. Yen.
1994.
Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm.
J. Virol.
68:3193-3199 |
| 16. | Huang, Z. M., and T. S. Yen. 1995. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15:3864-3869[Abstract]. |
| 17. |
Jaeger, J. A.,
D. H. Turner, and M. Zuker.
1989.
Improved predictions of secondary structures for RNA.
Proc. Natl. Acad. Sci. USA
86:7706-7710 |
| 18. |
Liu, X., and J. E. Mertz.
1995.
HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression.
Genes Dev.
9:1766-1780 |
| 19. | Nassal, M., and H. Schaller. 1993. Hepatitis B virus replication. Trends Microbiol. 1:221-228[Medline]. |
| 20. | Otero, G. C., M. E. Harris, J. E. Donello, and T. J. Hope. Unpublished data. |
| 21. |
Pace, N. R.,
D. K. Smith,
G. J. Olsen, and B. D. James.
1989.
Phylogenetic comparative analysis and the secondary structure of ribonuclease P RNA a review.
Gene
82:65-75[Medline].
|
| 22. | Pasquinelli, A. E., R. K. Ernst, M. L. Zapp, D. Rekosh, M.-L. Hammarskjold, and J. E. Dahlberg. 1997. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16:7500-7510[Medline]. |
| 23. |
Roth, J., and M. Dobbelstein.
1997.
Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor I B .
J. Virol.
71:8933-8939[Abstract].
|
| 24. | Saavedra, C., B. Felber, and E. Izaurralde. 1997. The simian retrovirus-1 CTE, unlike the HIV-1 RRE, uses factors required for the export of cellular mRNAs. Curr. Biol. 7:619-628[Medline]. |
| 25. | Shaul, Y., W. J. Rutter, and O. Laub. 1985. A human hepatitis B viral enhancer element. EMBO J. 4:427-430[Medline]. |
| 26. | Smith, G. J., J. E. Donello, and T. J. Hope. Unpublished data. |
| 27. |
Su, H., and J. K. Yee.
1992.
Regulation of hepatitis B virus gene expression by its two enhancers.
Proc. Natl. Acad. Sci. USA
89:2708-2712 |
| 28. |
Su, T. S.,
C. J. Lai,
J. L. Huang,
L. H. Lin,
Y. K. Yauk,
C. M. Chang,
S. J. Lo, and S. H. Han.
1989.
Hepatitis B virus transcript produced by RNA splicing.
J. Virol.
63:4011-4018 |
| 29. | Sugata, F., H. S. Chen, S. Kaneko, R. H. Purcell, and R. H. Miller. 1994. Analysis of the X gene promoter of woodchuck hepatitis virus. Virology 205:314-320[Medline]. |
| 30. |
Trujillo, M. A.,
J. Letovsky,
H. F. Maguire,
C. M. Lopez, and A. Siddiqui.
1991.
Functional analysis of a liver-specific enhancer of the hepatitis B virus.
Proc. Natl. Acad. Sci. USA
88:3797-3801 |
| 31. | Ueda, K., Y. Wei, and D. Ganem. 1996. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II. Virology 217:413-417[Medline]. |
| 32. | Ueda, K., Y. Wei, and D. Ganem. 1996. Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II. J. Virol. 70:4714-4723[Abstract]. |
| 33. |
Vannice, J. L., and A. D. Levinson.
1988.
Properties of the human hepatitis B virus enhancer: position effects and cell type nonspecificity.
J. Virol.
62:1305-1313 |
| 34. |
Yuh, C. H.,
Y. L. Chang, and L. P. Ting.
1992.
Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus.
J. Virol.
66:4073-4084 |
| 35. |
Yuh, C. H., and L. P. Ting.
1993.
Differentiated liver cell specificity of the second enhancer of hepatitis B virus.
J. Virol.
67:142-149 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. |
|---|